Gisela Di Venanzio

Gisela Di Venanzio

Auto-generated profile, based on publicly available information

Gisela Di Venanzio

Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, Missouri, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
GVGisela Di Venanzio
Gisela Di Venanzio
AFAna Lidia Flores-Mireles
Ana Lidia Flores-Mireles
JCJuan J. Calix
Juan J. Calix
MHM. Florencia Haurat
M. Florencia Haurat
NSNichollas E. Scott
Nichollas E. Scott
MFMario F. Feldman
Mario F. Feldman
Multidrug resistant (MDR) Acinetobacter baumannii poses a growing threat to global health. Research on Acinetobacter pathogenesis has primarily focused on pneumonia and bloodstream infections, even though one in five A. baumannii strains are isolated from urinary sites. In this study, we highlight the role of A. baumannii as a uropathogen. We develop the first A. baumannii catheter-associated urinary tract infection (CAUTI) murine model using UPAB1, a recent MDR urinary isolate. UPAB1 carries the plasmid pAB5, a member of the family of large conjugative plasmids that represses the type VI secretion system (T6SS) in multiple Acinetobacter strains. pAB5 confers niche specificity, as its carriage improves UPAB1 survival in a CAUTI model and decreases virulence in a pneumonia model. Comparative proteomic and transcriptomic analyses show that pAB5 regulates the expression of multiple chromosomally-encoded virulence factors besides T6SS. Our results demonstrate that plasmids can impact bacterial infections by controlling the expression of chromosomal genes.

2 February 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
YTYuli Talyansky
Yuli Talyansky
TNTravis B. Nielsen
Travis B. Nielsen
JYJun Yan
Jun Yan
UCUlrike Carlino-Macdonald
Ulrike Carlino-Macdonald
GVGisela Di Venanzio
Gisela Di Venanzio
BSBrad Spellberg
Brad Spellberg
Acinetobacter baumanniiis a highly antibiotic-resistant bacterial pathogen for which novel therapeutic approaches are needed. Unfortunately, the drivers of virulence inA.baumanniiremain uncertain. By comparing genomes among a panel ofA.baumanniistrains we identified a specific gene variation in the capsule locus that correlated with altered virulence. While less virulent strains possessed the intact genegtr6, a hypervirulent clinical isolate contained a spontaneous transposon insertion in the same gene, resulting in the loss of a branchpoint in capsular carbohydrate structure. By constructing isogenicgtr6mutants, we confirmed thatgtr6-disrupted strains were protected from phagocytosisin vitroand displayed higher bacterial burden and lethalityin vivo.Gtr6+ strains were phagocytized more readily and caused lower bacterial burden and no clinical illnessin vivo. We found that the CR3 receptor mediated phagocytosis ofgtr6+, but notgtr6-, strains in a complement-dependent manner. Furthermore, hypovirulentgtr6+strains demonstrated increased virulencein vivowhen CR3 function was abrogated. In summary, loss-of-function in a single capsule assembly gene dramatically altered virulence by inhibiting complement deposition and recognition by phagocytes across multipleA.baumanniistrains. Thus, capsular structure can determine virulence amongA.baumanniistrains by altering bacterial interactions with host complement-mediated opsonophagocytosis.

24 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
NLNguyen-Hung Le
Nguyen-Hung Le
KPKatharina Peters
Katharina Peters
AEAkbar Espaillat
Akbar Espaillat
JSJessica R. Sheldon
Jessica R. Sheldon
JGJoe Gray
Joe Gray
MFMario F. Feldman
Mario F. Feldman
Peptidoglycan (PG) is essential in most bacteria. Thus, it is often targeted by various assaults, including interbacterial attacks via the type VI secretion system (T6SS). Here, we report that the Gram-negative bacterium Acinetobacter baumannii strain ATCC 17978 produces, secretes, and incorporates the noncanonical d-amino acid d-lysine into its PG during stationary phase. We show that PG editing increases the competitiveness of A. baumannii during bacterial warfare by providing immunity against peptidoglycan-targeting T6SS effectors from various bacterial competitors. In contrast, we found that d-Lys production is detrimental to pathogenesis due, at least in part, to the activity of the human enzyme d-amino acid oxidase (DAO), which degrades d-Lys producing H2O2 toxic to bacteria. Phylogenetic analyses indicate that the last common ancestor of A. baumannii had the ability to produce d-Lys. However, this trait was independently lost multiple times, likely reflecting the evolution of A. baumannii as a human pathogen.

9 August 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
GSGabriela Sycz
Gabriela Sycz
GVGisela Di Venanzio
Gisela Di Venanzio
JDJesus S. Distel
Jesus S. Distel
MSMariana G. Sartorio
Mariana G. Sartorio
NLNguyen-Hung Le
Nguyen-Hung Le
MFMario F. Feldman
Mario F. Feldman
Multidrug-resistant Acinetobacter baumannii infections are increasing at alarming rates. Therefore, novel antibiotic-sparing treatments to combat these A. baumannii infections are urgently needed. The development of these interventions would benefit from a better understanding of this bacterium’s pathobiology, which remains poorly understood. A. baumannii is regarded as an extracellular opportunistic pathogen. However, research on Acinetobacter has largely focused on common lab strains, such as ATCC 19606, that have been isolated several decades ago. These strains exhibit reduced virulence when compared to recently isolated clinical strains. In this work, we demonstrate that, unlike ATCC 19606, several modern A. baumannii clinical isolates, including the recent clinical urinary isolate UPAB1, persist and replicate inside macrophages within spacious vacuoles. We show that intracellular replication of UPAB1 is dependent on a functional type I secretion system (T1SS) and pAB5, a large conjugative plasmid that controls the expression of several chromosomally-encoded genes. Finally, we show that UPAB1 escapes from the infected macrophages by a lytic process. To our knowledge, this is the first report of intracellular growth and replication of A. baumannii. We suggest that intracellular replication within macrophages may contribute to evasion of the immune response, dissemination, and antibiotic tolerance of A. baumannii.

18 January 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
KTKevin O. Tamadonfar
Kevin O. Tamadonfar
GVGisela Di Venanzio
Gisela Di Venanzio
JPJerome S. Pinkner
Jerome S. Pinkner
KDKaren W. Dodson
Karen W. Dodson
VKVasilios Kalas
Vasilios Kalas
SHScott J. Hultgren
Scott J. Hultgren
Multidrug-resistant Acinetobacter baumannii infections are an urgent clinical problem and can cause difficult-to-treat nosocomial infections. During such infections, like catheter-associated urinary tract infections (CAUTI), A. baumannii rely on adhesive, extracellular fibers, called chaperone-usher pathway (CUP) pili for critical binding interactions. The A. baumannii uropathogenic strain, UPAB1, and the pan-European subclone II isolate, ACICU, use the CUP pili Abp1 and Abp2 (previously termed Cup and Prp, respectively) in tandem to establish CAUTIs, specifically to facilitate bacterial adherence and biofilm formation on the implanted catheter. Abp1 and Abp2 pili are tipped with two domain tip adhesins, Abp1D and Abp2D, respectively. We discovered that both adhesins bind fibrinogen, a critical host wound response protein that is released into the bladder upon catheterization and is subsequently deposited on the catheter. The crystal structures of the Abp1D and Abp2D receptor-binding domains were determined and revealed that they both contain a large, distally oriented pocket, which mediates binding to fibrinogen and other glycoproteins. Genetic, biochemical, and biophysical studies revealed that interactions with host proteins are governed by several critical residues in and along the edge of the binding pocket, one of which regulates the structural stability of an anterior loop motif. K34, located outside of the pocket but interacting with the anterior loop, also regulates the binding affinity of the protein. This study illuminates the mechanistic basis of the critical fibrinogen-coated catheter colonization step in A. baumannii CAUTI pathogenesis.

11 January 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
JHJennie E. Hazen
Jennie E. Hazen
GVGisela Di Venanzio
Gisela Di Venanzio
SHScott J. Hultgren
Scott J. Hultgren
MFMario F. Feldman
Mario F. Feldman
The antibiotic-resistant bacteriumAcinetobacter baumanniiis a leading cause of hospital-associated infections. Despite surveillance and infection control efforts, newA. baumanniistrains are regularly isolated from health care facilities worldwide. In a mouse model of urinary tract infection, we found that mice infected withA. baumanniidisplayed high bacterial burdens in urine for several weeks. Two months after the resolution ofA. baumanniiinfection, inserting a catheter into the bladder of mice with resolved infection led to the resurgence of a same-strain urinary tract infection in ~53% of the mice within 24 hours. We identified intracellularA. baumanniibacteria in the bladder epithelial cells of mice with resolved infection, which we propose could act as a host reservoir that was activated upon insertion of a catheter, leading to a resurgent secondary infection.